Analysis of the Genomic Sequences and Metabolites of Bacillus velezensis YA215
- PMID: 38386213
- DOI: 10.1007/s10528-024-10710-y
Analysis of the Genomic Sequences and Metabolites of Bacillus velezensis YA215
Abstract
Discovering more novel antimicrobial compounds has become a keen research problem. In this study, YA215 genome was sequenced by the Illumina HiSeq + PacBio sequencing platform. Genome assembly was performed by Unicycler software and the gene clusters responsible for secondary metabolite biosynthesis were predicted by antiSMASH. The genome comprised 3976514 bp and had a 46.56% G + C content. 3809 coding DNA sequences, 27 rRNAs, 86 tRNAs genes, and 79 sRNA were predicted. Strain YA215 was re-identified as Bacillus velezensis based on ANI and OrthoANI analysis. In the COG database, 23 functional groups from 3090 annotations were predicted. In the GO database, 2654 annotations were predicted. 2486 KEGG annotations linked 41 metabolic pathways. Glycosyl transferases, polysaccharide lyases, auxiliary activities, glycoside hydrolases, carbohydrate esterases, and carbohydrate-binding modules were predicted among the 127 annotations in the CAZy database. AntiSMASH analysis predicted that B. velezensis YA215 boasted 13 gene clusters involved in synthesis of antimicrobial secondary metabolites including surfactin, fengycin, macrolactin H, bacillaene, difficidin, bacillibactin, bacilysin, and plantazolicin. Three of the gene clusters (gene cluster 5, gene cluster 9, and gene cluster 10) have the potential to synthesize unknown compounds. The research underscore the considerable potential of secondary metabolites, identified in the genomic composition of B. velezensis YA215, as versatile antibacterial agents with a broad spectrum of activity against pathogenic bacteria.
Keywords: Bacillus velezensis; Antimicrobial compounds; Gene cluster; Genome analysis; Secondary metabolites.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare that they have no conflicts of interest. Ethical Approval: Not required (This research did not involve humans or animals). Consent for Publication: All authors have read and approved this version of the article and due care has been taken to ensure the integrity of the work.
Similar articles
-
Whole genome analysis of Stenotrophomonas geniculata MK2 and antagonism against Botrytis cinerea in strawberry.Int Microbiol. 2024 Nov 27. doi: 10.1007/s10123-024-00612-9. Online ahead of print. Int Microbiol. 2024. PMID: 39602005
-
Tobacco Product Use and Associated Factors Among Middle and High School Students - National Youth Tobacco Survey, United States, 2021.MMWR Surveill Summ. 2022 Mar 11;71(5):1-29. doi: 10.15585/mmwr.ss7105a1. MMWR Surveill Summ. 2022. PMID: 35271557 Free PMC article.
-
Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.Health Technol Assess. 2024 Oct;28(73):1-230. doi: 10.3310/YAPL9347. Health Technol Assess. 2024. PMID: 39487661 Free PMC article.
-
Trends in Surgical and Nonsurgical Aesthetic Procedures: A 14-Year Analysis of the International Society of Aesthetic Plastic Surgery-ISAPS.Aesthetic Plast Surg. 2024 Oct;48(20):4217-4227. doi: 10.1007/s00266-024-04260-2. Epub 2024 Aug 5. Aesthetic Plast Surg. 2024. PMID: 39103642 Review.
-
Interventions for supporting pregnant women's decision-making about mode of birth after a caesarean.Cochrane Database Syst Rev. 2013 Jul 30;2013(7):CD010041. doi: 10.1002/14651858.CD010041.pub2. Cochrane Database Syst Rev. 2013. PMID: 23897547 Free PMC article. Review.
References
-
- Adeniji AA, Loots DT, Babalola OO (2019) Bacillus velezensis: phylogeny, useful applications, and avenues for exploitation. Appl Microbiol Biot 103(9):3669–3682. https://doi.org/10.1007/s00253-019-09710-5 - DOI
-
- Baltz RH (2021) Genome mining for drug discovery: cyclic lipopeptides related to daptomycin. J Ind Microbiol Biot. https://doi.org/10.1093/jimb/kuab020 - DOI
-
- Barale SS, Ghane SG, Sonawane KD (2022) Purification and characterization of antibacterial surfactin isoforms produced by Bacillus velezensis SK. AMB Express 12(1):7. https://doi.org/10.1186/s13568-022-01348-3 - DOI - PubMed - PMC
-
- Blin K, Shaw S, Steinke K, Villebro R, Ziemert N, Lee SY, Medema MH, Weber T (2019) antiSMASH 5.0: updates to the secondary metabolite genome mining pipeline. Nucleic Acids Res. https://doi.org/10.1093/nar/gkz310 - DOI - PubMed - PMC
-
- Canturri AM, Smani Y (2022) Anthelmintic drugs for repurposing against gram-negative Bacilli Infections. Curr Med Chem 30(1):59–71. https://doi.org/10.2174/0929867329666220714092916 - DOI - PubMed
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
